Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: AbCellera Receives Authorization From Health Canada To Initiate The Phase 1 Clinical Trial Of Abcl635 For Vasomotor Symptoms Due To Menopause

May 14 (Reuters) - Abcellera Biologics Inc ABCL.O:

ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE THE PHASE 1 CLINICAL TRIAL OF ABCL635 FOR VASOMOTOR SYMPTOMS DUE TO MENOPAUSE

ABCELLERA RECEIVES AUTHORIZATION FROM HEALTH CANADA TO INITIATE THE PHASE 1 CLINICAL TRIAL OF ABCL635 FOR VASOMOTOR SYMPTOMS DUE TO MENOPAUSE

ABCELLERA BIOLOGICS INC - PHASE 1 TRIAL FOR ABCL635 EXPECTED TO START IN Q3 2025

Source text: ID:nBw90vhPga

Further company coverage: ABCL.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AbCellera Biologics

See all news